# Post Approval Commitment Study

> **NCT01444729** · — · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 305 (actual)

## Conditions studied

- Dupuytren's Contracture

## Interventions

- **DRUG:** Xiapex
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT01444729
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444729, "Post Approval Commitment Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01444729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*